Yrjö Erik Kristian Wichmann
Director of Finance/CFO at FARON PHARMACEUTICALS OY
Net worth: 122 188 $ as of 2024-06-29
Profile
Yrjö Erik Kristian Wichmann founded Silicon Laboratories Finland Oy in 2000, where he worked as Director from 2000 to 2005.
Mr. Wichmann also currently works at the University of Helsinki, as Member-Innovation Board, Dasos Timberland Fund I SCA SICAV FIS, as Member-Investment Committee, Dasos Timberland Fund II SCA SICAV FIS, as Member-Investment Committee, and Faron Pharmaceuticals Oy, as Chief Financial Officer from 2024.
Mr. Wichmann also formerly worked at Chip-Man Technologies Oy, as Chairman, CapMan Capital Management Oy, as Fundraising Director, Bioretec Ltd., as Director, IP Finland Oy, as Director, CapMan AB, as Investment Director, Biohit Oyj, as Head-Diagnostic Division, Hembla AB, as Investment Banker, Postipankki, as Investment Banker, FibroGen Europe Oy, as Chief Financial Officer, and Faron Pharmaceuticals Oy, as Chief Financial Officer in 2019.
Mr. Wichmann received his graduate degree from the University of Helsinki.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
FARON PHARMACEUTICALS OY
0.09% | 2024-06-19 | 98,132 ( 0.09% ) | 122 188 $ | 2024-06-29 |
Yrjö Erik Kristian Wichmann active positions
Companies | Position | Start |
---|---|---|
FARON PHARMACEUTICALS OY | Director of Finance/CFO | 2024-04-14 |
Dasos Timberland Fund I SCA SICAV FIS
Dasos Timberland Fund I SCA SICAV FIS Investment ManagersFinance Dasos Timberland Fund I SCA SICAV FIS invests in forestry projects globally with an emphasis on Europe and emerging countries. At least 40 % of the fund's assets are placed in Europe and the rest in emerging countries. The fund promotes sustainable projects which preserve natural resources and addresses three major environmental issues such as climate change, soil and freshwater conservation and biodiversity. It aims at a well-diversified global timberland portfolio with an objective of generating early cash flow. The fund has an investment period of four years, which might be extended by a period of one year, and a life-span of 15 years. The minimum suscription per investor is EUR 5 million and the expected return is at least 10 %. | Corporate Officer/Principal | - |
Dasos Timberland Fund II SCA SICAV FIS
Dasos Timberland Fund II SCA SICAV FIS Investment ManagersFinance Dasos Timberland Fund II SCA SICAV FIS invests in companies located globally primarily in Europe and emerging countries. The fund targets companies operating in forest products. It provides financing for buyout transactions. | Corporate Officer/Principal | - |
University of Helsinki | Corporate Officer/Principal | - |
Former positions of Yrjö Erik Kristian Wichmann
Companies | Position | End |
---|---|---|
Silicon Laboratories Finland Oy
Silicon Laboratories Finland Oy Computer CommunicationsElectronic Technology Silicon Laboratories Finland Oy provides short-range wireless connectivity solutions and software for the Internet of Things. It offers wireless modules, software stacks, development tools, and software development kits for applications in the industrial automation, consumer electronics, audio, automotive, retail, residential, health, and fitness markets. The company was founded by Tom Nordman and Hans Holmberg in 2000 and is headquartered in Espoo, Finland. | Founder | 2005-02-28 |
CapMan AB
CapMan AB Investment ManagersFinance Capman AB operates as a private equity and venture capital firm. It offers investment strategic services. The company is headquartered in Stockholm, Sweden. | Chief Investment Officer | - |
FARON PHARMACEUTICALS OY | Director of Finance/CFO | 2019-05-31 |
Chip-Man Technologies Oy
Chip-Man Technologies Oy Miscellaneous Commercial ServicesCommercial Services CM Technologies Oy develops and markets automated systems for cell imaging and tissue research laboratories. Its Cell-IQ platforms are used for plethora of applications from cell biology, functional genomics, drug discovery, in vitro fertilization, in vitro toxicology, stem cell research, and regenerative medicine by researchers in pharmaceutical, biotechnology, academic research institutes, government, and hospital facilities. Its Cell-IQ combines Cell Maintenance, Monitoring, and Cellular Measurements and is a system for live cell imaging and analysis for long term or short term studies. Its product Cell-IQ PC (Phase Contrast), is an integrated continuous live cell imaging and analysis platform incorporating phase contrast and bright field imaging capability; Cell-IQ SLF (Single-Label Fluorescence), which has fluorescence imaging capability; and Cell-IQ MLF (Multi-Label Fluorescence), which expands the fluorescence capability to image 3. The company was founded in 2002 and is headquartered in Tampere, Finland. | Chairman | - |
CapMan Capital Management Oy
CapMan Capital Management Oy Investment ManagersFinance CapMan Capital Management Oy (CapMan Capital Management) is a private equity subsidiary of CapMan Oyj founded in 1989. The firm is headquartered in Helsinki, Finland. | Corporate Officer/Principal | - |
Training of Yrjö Erik Kristian Wichmann
University of Helsinki | Graduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
BIOHIT OYJ | Health Technology |
BIORETEC OY | Health Technology |
FARON PHARMACEUTICALS OY | Health Technology |
Private companies | 10 |
---|---|
IP Finland Oy
IP Finland Oy Miscellaneous Commercial ServicesCommercial Services IP Finland Oy provides research and development services. It specializes in the commercialization of research-based intellectual property. The company is headquartered in Helsinki, Finland. | Commercial Services |
Fibrogen Europe Oy
Fibrogen Europe Oy BiotechnologyHealth Technology Fibrogen Europe Oy develops and markets recombinant human collagens and gelatins for research purposes. It serves companies in the pharmaceutical, vaccine, medical device, diagnostic, industrial, food, cosmetic, and nutraceutical businesses. The company was founded on May 22, 1996 and is located at Helsinki, Finland. | Health Technology |
Silicon Laboratories Finland Oy
Silicon Laboratories Finland Oy Computer CommunicationsElectronic Technology Silicon Laboratories Finland Oy provides short-range wireless connectivity solutions and software for the Internet of Things. It offers wireless modules, software stacks, development tools, and software development kits for applications in the industrial automation, consumer electronics, audio, automotive, retail, residential, health, and fitness markets. The company was founded by Tom Nordman and Hans Holmberg in 2000 and is headquartered in Espoo, Finland. | Electronic Technology |
Postipankki
Postipankki Regional BanksFinance Postipankki Oyj provides lending and other banking services in Finland with branch offices in London, New York and Singapore and representative offices in Moscow, Tokyo, Stockholm and Tallinn. Lending to private consumers accounted for 43% of domestic loan portfolio in 1997; corporate sector, 23%; public sector, 15%; financial institutions, 15% and other, 4%. Interest income accounted for 84% of 1997 revenues; commissions and fees, 13%; foreign exchange income, 2% and leasing, securities income and other, 1%. | Finance |
Hembla AB
Hembla AB Real Estate DevelopmentFinance Hembla AB engages in the management of residential properties. Its project portfolio includes apartments and condominiums. The company was founded in 1803 and is headquartered in Stockholm, Sweden. | Finance |
CapMan Capital Management Oy
CapMan Capital Management Oy Investment ManagersFinance CapMan Capital Management Oy (CapMan Capital Management) is a private equity subsidiary of CapMan Oyj founded in 1989. The firm is headquartered in Helsinki, Finland. | Finance |
Chip-Man Technologies Oy
Chip-Man Technologies Oy Miscellaneous Commercial ServicesCommercial Services CM Technologies Oy develops and markets automated systems for cell imaging and tissue research laboratories. Its Cell-IQ platforms are used for plethora of applications from cell biology, functional genomics, drug discovery, in vitro fertilization, in vitro toxicology, stem cell research, and regenerative medicine by researchers in pharmaceutical, biotechnology, academic research institutes, government, and hospital facilities. Its Cell-IQ combines Cell Maintenance, Monitoring, and Cellular Measurements and is a system for live cell imaging and analysis for long term or short term studies. Its product Cell-IQ PC (Phase Contrast), is an integrated continuous live cell imaging and analysis platform incorporating phase contrast and bright field imaging capability; Cell-IQ SLF (Single-Label Fluorescence), which has fluorescence imaging capability; and Cell-IQ MLF (Multi-Label Fluorescence), which expands the fluorescence capability to image 3. The company was founded in 2002 and is headquartered in Tampere, Finland. | Commercial Services |
CapMan AB
CapMan AB Investment ManagersFinance Capman AB operates as a private equity and venture capital firm. It offers investment strategic services. The company is headquartered in Stockholm, Sweden. | Finance |
Dasos Timberland Fund I SCA SICAV FIS
Dasos Timberland Fund I SCA SICAV FIS Investment ManagersFinance Dasos Timberland Fund I SCA SICAV FIS invests in forestry projects globally with an emphasis on Europe and emerging countries. At least 40 % of the fund's assets are placed in Europe and the rest in emerging countries. The fund promotes sustainable projects which preserve natural resources and addresses three major environmental issues such as climate change, soil and freshwater conservation and biodiversity. It aims at a well-diversified global timberland portfolio with an objective of generating early cash flow. The fund has an investment period of four years, which might be extended by a period of one year, and a life-span of 15 years. The minimum suscription per investor is EUR 5 million and the expected return is at least 10 %. | Finance |
Dasos Timberland Fund II SCA SICAV FIS
Dasos Timberland Fund II SCA SICAV FIS Investment ManagersFinance Dasos Timberland Fund II SCA SICAV FIS invests in companies located globally primarily in Europe and emerging countries. The fund targets companies operating in forest products. It provides financing for buyout transactions. | Finance |
- Stock Market
- Insiders
- Yrjö Erik Kristian Wichmann